Cerium oxide nanoparticles alter the salt stress tolerance of Brassica napus L. by modifying the formation of root apoplastic barriers.

Rapidly growing global population adds significant strains on the fresh water resources. Consequently, saline water is increasingly tapped for crop irrigation. Meanwhile, rapid advancement of nanotechnology is introducing more and more engineered nanoparticles into the environment and in agricultural soils. While some negative effects of ENPs on plant health at very high concentrations have been reported, more beneficial effects of ENPs at relatively low concentrations are increasingly noticed, opening doors for potential applications of nanotechnology in agriculture. In particular, we found that cerium oxide nanoparticles (CeO2NPs) improved plant photosynthesis in salt stressed plants. Due to the close connections between salt stress tolerance and the root anatomical structures, we postulated that CeO2NPs could modify plant root anatomy and improve plant salt stress tolerance. This study aimed at testing the hypothesis with Brassica napus in the presence of CeO2NPs (0, 500 mg kg-1 dry sand) and/or NaCl (0, 50 mM) in a growth chamber. Free hand sections of fresh roots were taken every seven days for three weeks and the suberin lamellae development was examined under a fluorescence microscope. The results confirmed the hypothesis that CeO2NPs modified the formation of the apoplastic barriers in Brassica roots. In salt stressed plants, CeO2NPs shortened the root apoplastic barriers which allowed more Na+ transport to shoots and less accumulation of Na+ in plant roots. The altered Na+ fluxes and transport led to better physiological performance of Brassica and may lead to new applications of nanotechnology in agriculture.

Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies

ABSTRACT Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesartan loaded SLNs were characterized and optimized by parameters like particle size, zeta potential, surface morphology entrapment efficiency and in vitro release. The optimized formulation was then further evaluated for the pharmacokinetic studies in Wistar rats. Irbesartan-loaded SLN of particle size 523.7 nm and 73.8% entrapment efficiency showed good bioavailability in Wistar rats and also showed optimum stability in the studies. The SLN prepared using glyceryl monostearate by solvent emulsification method leads to improve bioavailability of the drug.

Ameliorating the antitumor activity of lenalidomide using PLGA nanoparticles for the treatment of multiple myeloma

Abstract Lenalidomide (LND) is an anti-cancer drug and an effective derivative of thalidomide used for multiple myeloma therapy. Because of its poor solubility in water, LND is known to cause low oral bioavailability (below 33%), and as a direct consequence of this, the dosing frequency is extended thus increasing risk of toxicity. To improve its bioavailability and sustained release, the present study aims to formulate polymeric nanoparticles (NPs) for LND using [Poly (lactic-co-glycolic acid)] (PLGA) as a polymer. The polymeric NPs were evaluated for particle size, SEM, XRD, drug content, entrapment efficiency (EE), in vitro release studies and in vivo bioavailability studies in rats. The formulated NPs possessed a size of 179±0.9 nm and a zeta potential of -24.4 ± 0.2 mV. The drug loading and EE of the optimized formulation was 32 ± 0.37 % and 78 ± 0.92% respectively. After oral administration of LND PLGA-NPs, the relative bioavailability was enhanced about 3.67-fold compared to LND. This study demonstrates the novel drug delivery for LND with PLGA-NPs as effective drug delivery system for sustained delivery of LND.

Development of a new HPLC method for in vitro and in vivo studies of haloperidol in solid lipid nanoparticles

ABSTRACT A simple and sensitive HPLC method was developed and validated for the quantification of haloperidol in solid lipid nanoparticles (SLNs). The developed method was used for detection of shelf life of haloperidol in SLNs. Calibration curve of haloperidol was also constructed in rat plasma using loratidine as internal standard. In vivo studies were performed on rats and concentration of haloperidol in brain and blood was measured for the determination of various pharmacokinetic and hence brain targeting parameters. Chromatogram separation was achieved using C18 column as stationary phase. The mobile phase consisted of 100 mM/L potassium dihydrogen phosphate-acetonitrile-TEA (10:90:0.1, v/v/v) and the pH was adjusted with o-phosphoric acid to 3.5. Flow rate of mobile phase was 2 mL/minute and eluents were monitored at 230 nm using UV/VIS detector. The method was validated for linearity, precision, accuracy, reproducibility, limit of detection (LOD) and limit of quantification (LOQ). Linearity for haloperidol was in the range of 1-16 µg/mL. The value of LOD and LOQ was found to be 0.045 and 0.135 μg/mL respectively. The shelf life of SLNs formulation was found to be 2.31 years at 4 oC. Various parameters like drug targeting index (DTI), drug targeting efficiency (DTE) and nose-to-brain direct transport (DTP) were determined for HP-SLNs & HP-Sol administered intranasally to evaluate the extent of nose-to-brain delivery. The value of DTI, DTE and DTP for HP-SLNs was found to be 23.62, 2362.43 % and 95.77% while for HP-Sol, values were 11.28, 1128.61 % and 91.14 % respectively.

A simple HPLC method for the determination of halcinonide in lipid nanoparticles: development, validation, encapsulation efficiency, and in vitro drug permeation

ABSTRACT Halcinonide is a high-potency topical glucocorticoid used for skin inflammation treatments that presents toxic systemic effects. A simple and quick analytical method to quantify the amount of halcinonide encapsulated into lipid nanoparticles, such as polymeric lipid-core nanoparticles and solid lipid nanoparticles, was developed and validated regarding the drug's encapsulation efficiency and in vitro permeation. The development and validation of the analytical method were carried out using the high performance liquid chromatography with the UV detection at 239 nm. The validation parameters were specificity, linearity, precision and accuracy, limits of detection and quantitation, and robustness. The method presented an isocratic flow rate of 1.0 mL.min-1, a mobile phase methanol:water (85:15 v/v), and a retention time of 4.21 min. The method was validated according to international and national regulations. The halcinonide encapsulation efficiency in nanoparticles was greater than 99% and the in vitro drug permeation study showed that less than 9% of the drug permeated through the membrane, indicating a nanoparticle reservoir effect, which can reduce the halcinonide's toxic systemic effects. These studies demonstrated the applicability of the developed and validated analytical method to quantify halcinonide in lipid nanoparticles.

Controlling DNA-nanoparticle serum interactions.

Understanding the interaction of molecularly assembled nanoparticles with physiological fluids is critical to their use for in vivo delivery of drugs and contrast agents. Here, we systematically investigated the factors and mechanisms that govern the degradation of DNA on the nanoparticle surface in serum. We discovered that a higher DNA density, shorter oligonucleotides, and thicker PEG layer increased protection of DNA against serum degradation. Oligonucleotides on the surface of nanoparticles were highly resistant to DNase I endonucleases, and degradation was carried out exclusively by protein-mediated exonuclease cleavage and full-strand desorption. These results enabled the programming of the degradation rates of the DNA-assembled nanoparticle system from 0.1 to 0.7 h-1 and the engineering of superstructures that can release two different preloaded dye molecules with distinct kinetics and half-lives ranging from 3.3 to 9.8 h. This study provides a general framework for investigating the serum stability of DNA-containing nanostructures. The results advance our understanding of engineering principles for designing nanoparticle assemblies with controlled in vivo behavior and present a strategy for storage and multistage release of drugs and contrast agents that can facilitate the diagnosis and treatment of cancer and other diseases.

Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.

Multiple sclerosis (MS) is an autoimmune neurodegenerative disease characterized with immunopathobiological events, including lymphocytic infiltration into the central nervous system (CNS), microglia activation, demyelination and axonal degeneration. Although several neuroprotective drugs have been designed for the treatment of MS, complete remission is yet matter of debate. Therefore, development of novel therapeutic approaches for MS is of a high priority in immunological research. Nanomedicine is a recently developed novel medical field, which is applicable in both diagnosis and treatment of several cancers and autoimmune diseases. Although there is a marked progress in neuroimaging through using nanoparticles, little is known regarding the therapeutic potential of nanomedicine in neurological disorders, particularly MS. Moreover, the majority of data is limited to the MS related animal models. In this review, we will discuss about the brain targeting potential of different nanoparticles as well as the role of nanomedicine in the diagnosis and treatment of MS and its animal model, experimental autoimmune encephalomyelitis.

Pro-haloacetate Nanoparticles for Efficient Cancer Therapy via Pyruvate Dehydrogenase Kinase Modulation.

Anticancer agents based on haloacetic acids are developed for inhibition of pyruvate dehydrogenase kinase (PDK), an enzyme responsible for reversing the suppression of mitochondria-dependent apoptosis. Through molecular docking studies mono- and dihaloacetates are identified as potent PDK2 binders and matched their efficiency with dichloroacetic acid. In silico screening directed their conversion to phospholipid prodrugs, which were subsequently self-assembled to pro-haloacetate nanoparticles. Following a thorough physico-chemical characterization, the functional activity of these novel agents was established in wide ranges of human cancer cell lines in vitro and in vivo in rodents. Results indicated that the newly explored PDK modulators can act as efficient agent for cancer regression. A Pyruvate dehydrogenase (PDH) assay mechanistically confirmed that these agents trigger their activity through the mitochondria-dependent apoptosis.

Development of nanostructures in the diagnosis of drug hypersensitivity reactions.

PURPOSE OF REVIEW: This article provides an overview of novel nanoscale structures potentially applicable to the field of allergy, and to discuss the required properties, advantages, and disadvantages of those nanostructures for clinical application focusing on diagnosis of drug hypersensitivity reactions. RECENT FINDINGS: Advances in the development of different nanostructures are favoring their biomedical applications. One area of interest is the interaction between nanostructures and the immune system, including their ability to emulate carrier molecules and their potential use for the diagnosis of allergic reactions. SUMMARY: Immunoassays are the most widely used in-vitro test for evaluating immunoglobulin E (IgE)-mediated drug hypersensitivity reactions. However, they have important technical limitations affecting their sensitivity. A wide variety of nanostructures have been designed to quantify specific IgE, with the aim of diagnosing different kinds of allergies. Nanoparticles-based colloidal immunoassay employed in microdevices and/or miniaturized systems are improving IgE detection sensitivity. Dendrimers have shown immense potential for the design and development of sensor platforms for evaluating IgE-mediated drug hypersensitivity reactions, due to the increase in hapten density and IgE accessibility. In this sense, a variety of dendritic structures as well as their hybridization to different solid supports have been shown to be successful when applied in the diagnosis of drug allergy. Moreover, the knowledge of the complete antigenic determinants would allow their inclusion and therefore further improvement of the sensitivity.

Inventory of Engineered Nanoparticle-Containing Consumer Products Available in the Singapore Retail Market and Likelihood of Release into the Aquatic Environment.

Consumer products containing engineered nanoparticles (ENP) are already entering the marketplace. This leads, inter alia, to questions about the potential for release of ENP into the environment from commercial products. We have inventoried the prevalence of ENP-containing consumer products in the Singapore market by carrying out onsite assessments of products sold in all major chains of retail and cosmetic stores. We have assessed their usage patterns and estimated release factors and emission quantities to obtain a better understanding of the quantities of ENP that are released into which compartments of the aquatic environment in Singapore. Products investigated were assessed for their likelihood to contain ENP based on the declaration of ENP by producers, feature descriptions, and the information on particle size from the literature. Among the 1,432 products investigated, 138 were "confirmed" and 293 were "likely" to contain ENP. Product categories included sunscreens, cosmetics, health and fitness, automotive, food, home and garden, clothing and footwear, and eyeglass/lens coatings. Among the 27 different types of nanomaterials identified, SiO2 was predominant, followed by TiO2 and ZnO, Carbon Black, Ag, and Au. The amounts of ENP released into the aquatic system, which was estimated on the basis of typical product use, ENP concentration in the product, daily use quantity, release factor, and market share, were in the range of several hundred tons per year. As these quantities are likely to increase, it will be important to further study the fate of ENP that reach the aquatic environment in Singapore.

Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications.

Copper nanoparticles have been the focus of intensive study due to their potential applications in diverse fields including biomedicine, electronics, and optics. Copper-based nanostructured materials have been used in conductive films, lubrification, nanofluids, catalysis, and also as potent antimicrobial agent. The biogenic synthesis of metallic nanostructured nanoparticles is considered to be a green and eco-friendly technology since neither harmful chemicals nor high temperatures are involved in the process. The present review discusses the synthesis of copper nanostructured nanoparticles by bacteria, fungi, and plant extracts, showing that biogenic synthesis is an economically feasible, simple and non-polluting process. Applications for biogenic copper nanoparticles are also discussed.

How the number of fitting points for the slope of the mean-square displacement influences the experimentally determined particle size distribution from single-particle tracking.

The size distribution of nanoparticles can be determined by single-particle tracking. This yields the mean-squared displacement (MSD) as a function of the lag time, and for normal diffusion the slope of this curve is directly related to the diffusion coefficient or via the Stokes-Einstein relation to the particle size. Here we demonstrate how the experimentally determined size distributions are affected by the number of fitting points used to determine the slope of the MSD curve.

Desenvolvimento, caracterização, avaliação da estabilidade e da penetração cutânea de nanopartículas de ácido ursólico incorporadas em formulação cosmética / Development, characterization, evaluation of stability and skin penetration of ursolic acid nanoparticles incorporated in cosmetic formulation

A indústria cosmética tem investido em tecnologias inovadoras na busca de maior eficácia de seus produtos. A Nanotecnologia tem sido utilizada com o propósito de desenvolver formulações de menor risco de irritação cutânea e que promovam a liberação modificada do componente ativo. Este trabalho teve como objetivo geral desenvolvimento, caracterização e avaliação de nanopartículas de ácido ursólico incorporadas em formulação cosmética. Nesta pesquisa, para determinar a eficiência de encapsulação do AU (ácido ursólico) livre e nas nanopartículas poliméricas, foi validada uma metodologia que empregou a CLAE (Cromatografia em fase Líquida de Alta Eficiência) e os resultados obtidos indicaram boa reprodutibilidade do método e concordância entre os resultados obtidos, sendo a metodologia empregada na avaliação do AU livre e nanoparticulado. As nanopartículas contendo AU apresentaram características de potencial estabilidade química, obtendo eficiência de encapsulação de 80% de AU para as nanopartículas poliméricas e 100% para os carreadores lipídicos nanoestruturados. A caracterização físico-química das nanopartículas poliméricas contendo AU foi realizada determinando-se diâmetro da partícula (353,4 ± 1,4 nm), índice de polidispersividade (0,106 ± 0,008) e potencial zeta (-35,6 ± 1,2 mV). Os resultados obtidos para os carreadores lipídicos nanoestruturados contendo AU nas formulações foram: tamanho de partícula entre 125,3±40,4 e 237,4±62,7 nm, índice de polidispersividade entre 0,01 e 0,38 e potencial zeta entre -20,5±9,2 e -50,7±9,5 mV. Os resultados obtidos indicaram estabilidade das nanopartículas desenvolvidas. O resultado relativo ao planejamento fatorial para otimização dos agentes tensoativos revelou modelo matemático de segunda ordem para a previsão de valores de potencial zeta em função das concentrações de SDS. Dessa forma, foi possível a preparação de carreador lipídico nanoestruturado contendo reduzida concentração de SDS e valor de potencial zeta menor...

The cosmetic industry has invested in innovative technologies in search of greater effectiveness of their products. Nanotechnology has been used with this propose to reduce the risk of skin irritation by promoting the modified release of the active component. This study had as main objective development, characterization and evaluation of ursolic acid nanoparticles incorporated in cosmetic formulation. In this research, to determine the entrapment efficiency of UA (ursolic acid) free and in polymeric nanoparticles, a methodology was validated using HPLC (high performance liquid chromatography) and the results indicated good reproducibility of the method and agreement between the results, the methodology employed could be assessed in the evaluation of free and UA nanoparticles. Nanoparticles containing UA showed characteristics of potential chemical stability obtaining entrapment efficiency of 80% for UA polymer nanoparticles and 100% for the nanostructured lipid carriers. The physicochemical characterization of polymeric nanoparticles containing UA was accomplished by determining the particle diameter (353.4 ± 1.4 nm), polydispersity index (0.106 ± 0.008) and zeta potential (-35.6 ± 1.2mV). The results obtained for the nanostructured lipid carriers containing UA formulations were: particle size between 125.3±40.4 and 237.4±62.7 nm, polydispersity index between 0.01 and 0.38, and zeta potential between -20.5±9.2 and -50.7±9.5 mV. The results indicated stability of the developed nanoparticles. The result for the factorial design for optimization of surfactant revealed a quadratic effect of the independent variable sodium dodecyl sulfate in zeta potential. Thus, it was possible to prepare nanostructured lipid carrier containing reduced concentrations of SDS and zeta potential value of less than -40 mV. By means of the techniques of TG/DTG and DSC, was observed that the UA remained stable. Cosmetic formulations containing free ursolic acid (AUL) and incorporated...

Potential exposure of German consumers to engineered nanoparticles in cosmetics and personal care products.

The rapid increase in the number of consumer products containing engineered nanoparticles (ENP) raises concerns about an appropriate risk assessment of these products. Along with toxicological data, exposure estimates are essential for assessing risk. Currently, cosmetics and personal care products (C&PCP) represent the largest ENP-containing consumer product class on the market. We analyzed factors influencing the likelihood that ENP-containing products are available to consumers. We modelled potential external exposure of German consumers, assuming a maximum possible case where only ENP-containing products are used. The distribution of exposure levels within the population due to different behavior patterns was included by using data from an extensive database on consumer behavior. Exposure levels were found to vary significantly between products and between consumers showing different behavior patterns. The assessment scheme developed here represents a basis for refined exposure modelling as soon as more specific information about ENPs in C&PCP becomes available.

Applications of nanoparticles in ophthalmology.

Nanocarriers, such as nanoparticles, have the capacity to deliver ocular drugs to specific target sites and hold promise to revolutionize the therapy of many eye diseases. Results to date strongly suggest that ocular medicine will benefit enormously from the use of this nanometric scale technology. One of the most important handicaps of the eye as a target organ for drugs is the presence of several barriers that impede direct and systemic drug access to the specific site of action. Superficial barriers include the ocular surface epithelium and the tear film, and internal barriers include the blood-aqueous and blood-retina barriers. Topical application is the preferred route for most drugs, even when the target tissues are at the back part of the eye where intraocular injections are currently the most common route of administration. Direct administration using any of these two routes faces many problems related to drug bioavailability, including side effects and repeated uncomfortable treatments to achieve therapeutic drug levels. In this regard, the advantages of using nanoparticles include improved topical passage of large, poorly water-soluble molecules such as glucocorticoid drugs or cyclosporine for immune-related, vision-threatening diseases. Other large and unstable molecules, such as nucleic acids, delivered using nanoparticles offer promising results for gene transfer therapy in severe retinal diseases. Also, nanoparticle-mediated drug delivery increases the contact time of the administered drug with its target tissue, such as in the case of brimonidine, one of the standard treatments for glaucoma, or corticosteroids used to treat autoimmune uveitis, a severe intraocular inflammatory process. In addition, nanocarriers permit the non-steroidal anti-inflammatory drug indomethacin to reach inner eye structures using the transmucosal route. Finally, nanoparticles allow the possibility of targeted delivery to reach specific types of cancer, such as melanoma, leaving normal cells untouched. This review summarizes experimental results from our group and others since the beginnings of nanocarrier technology to deliver drugs to different locations in the eye. Also, it explores the future possibilities of nanoparticles not only as drug delivery systems but also as aides for diagnostic purposes.

Análise térmica de uma resina composta de nanopartículas: caracterização e envelhecimento / Thermal analysis of nanofilled composite resin: characterization and aging

O objetivo deste estudo foi acompanhar o envelhecimento de uma resina composta de nanopartículas (Concept Advanced®) ao longo de um ano. A caracterização e a avaliação de sua homogeneidade foram realizadas após o envase em seringa de apresentação comercial por meio de Termogravimetria (TG/DTG), Calorimetria Exploratória Diferencial (DSC) e Análise Termomecânica (TMA). No grupo 1, foram realizadas 15 análises ao longo de seringas que não foram submetidas à pressão do êmbolo. Nos grupos 2 e 3, a resina composta foi totalmente removida pela torção do êmbolo e subdividida em cinco porções. Contudo, ao longo do tempo, no grupo 2, as seringas foram mantidas na vertical e no grupo 3, na horizontal. No grupo 4, cada amostra foi obtida de 24 em 24 horas da área central de cada porção por cinco dias. A análise dos diferentes grupos foi realizada em três seringas para os tempos: inicial, seis meses e um ano. As curvas TG/DTG foram obtidas em amostras não polimerizadas, seguindo programa de aquecimento de 25 a 650ºC, em atmosfera dinâmica de ar. A DSC e a TMA foram realizadas apenas no grupo 1, no tempo inicial, para caracterização do material em amostras fotoativadas de 3mm de diâmetro x 1mm de espessura por 20 segundos. As curvas DSC foram obtidas seguindo o programa de aquecimento da temperatura ambiente a 250°C, sob fluxo de nitrogênio. A TMA foi realizada em atmosfera de nitrogênio da temperatura ambiente a 150oC. As curvas TG/DTG de cada área analisada mostraram o mesmo padrão de decomposição em três etapas com percentuais de perda de massa semelhantes entre todas as amostras independente do tempo de armazenamento. Também o resíduo final, considerado como percentual de carga inorgânica, ficou em torno de 71,5% mostrando homogeneidade de distribuição ao longo das seringas. A pressão contínua determinou alteração estatisticamente significante na estabilidade térmica (p<0,05). Na DSC, as curvas mostraram temperatura de transição vítrea na faixa de 94 a 105ºC e um evento exotérmico a ~160ºC relacionado à polimerização secundária da resina composta. A TMA mostrou três faixas de alterações dimensionais e os valores do coeficiente de expansão térmica linear variaram dentro da mesma seringa, não mostrando homogeneidade de resultados.

The aim of this study was to evaluate the aging of a nanofilled composite resin (Concept Advanced®) during one year. The characterization and evaluation of its homogeneity in commercial syringe was made by Thermogravimetric Analysis (TG/DTG), Differential Scanning Calorimetry (DSC) and Thermomechanical Analysis (TMA). In group 1, 15 analyses throughout syringes were carried without pressing the pestle screw. In groups 2 and 3, the composite resin was all pressed out by the pestle screw and divided in five portions. However, in group 2, throughout the time, the syringes had been kept in the vertical position and group 3 in the horizontal position. In group 4, each sample was obtained every 24 in 24 hours from the central area of each portion during five days. All the analyses of groups 1, 2, 3 and 4 were carried through three syringes in the following times: initial, 6 months and one year. The TG/DTG analyses were carried in not polymerized samples, following a thermal program from 25 to 650ºC, under dynamic air atmosphere. The DSC and the TMA were just carried in group 1, in the initial time, to characterize the material in polymerized samples of 3mm diameter x 1mm thickness per 20 seconds. The curves DSC were obtained following the thermal program from room temperature to 250°C under a nitrogen flow. The TMA was carried under a nitrogen atmosphere from room temperature to 150°C. The curves of TG/DTG showed similar patterns of decomposition in three stages, in all groups independent of the storage time, with similar percentages of loss of mass. Also the weight fraction of inorganic fillers was around 71.5%, showing homogeneity of distribution throughout the syringes. The continuous pressure determined significant alteration in the thermal stability (p< 0,05). The DSC curves showed a glass transition ranged between 94 and 105ºC and eventually an exotherm event at ~160ºC. The TMA showed that the values of the linear coefficient of thermal expansion had varied inside of the same syringe

[Nanotechnology and nanoparticles--state of the problem, objectives of industrial medicine].

The article deals with contemporary state of studies in a sphere of nanostructures and nanomaterials influence on human health, potential risks associated with usage of those structures and materials. The authors determine objectives of industrial medicine in connection with application of nanotechnologies and nanomaterials in production and everyday life.